Can inhaled corticosteroids alleviate early symptoms of COVID-19?
Results from the CONTAIN study conducted at the RI-MUHC reveal that ciclesonide is no better than placebo
Regular screening for tuberculosis in Inuit communities is cost-effective
A new study from RI-MUHC researchers published in CMAJ recommends regular screening to help reduce outbreaks
Ben Geboe awarded the 2021-2022 Dr. Margaret Becklake Fellowship for his research with urban Indigenous populations
The RI-MUHC postdoc is working on a culturally safe framework for TB...
RI-MUHC researchers tackle COVID-19 vaccine hesitancy in adults and in children
Videos from projects led by Drs. Inés Colmegna and Moshe Ben-Shoshan are now available
RI-MUHC leads study of antiviral use in children hospitalized for influenza
Findings show that influenza antivirals are underutilized in Canadian pediatric hospitals, despite national clinical...
Two members of the RI-MUHC elected fellows of the Canadian Academy of Health Sciences
Congratulations to Jean Bourbeau and Togas Tulandi!
Research trainees are bridging the gap between science and the public
Two RI-MUHC research trainees share their experience as community outreach panelists
RI-MUHC researcher Sasha Bernatsky leads nationwide COVID-19 vaccination study
New study will assess impact of the vaccines on Canadians with immune-mediated inflammatory disease
App-based HIV self-testing program leads to rapid detection of new infections and efficient connection to care
A unique new study shows that self-testing with the HIVSmart! program...
New cancer screening tool may help childhood cancer survivors
A novel cancer predisposition screening tool shows promise in helping doctors better predict which childhood cancer survivors may be at risk of developing...